OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study
Lei Huang, Yao Lv, Shasha Guan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Lei Huang, Yao Lv, Shasha Guan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
Dong Luo, Yunmei Liu, Zhengmao Lu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Dong Luo, Yunmei Liu, Zhengmao Lu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
A Review of Circulating Tumor DNA (ctDNA) in Pancreatic Cancer: Ready for the Clinic?
Purvi Jonnalagadda, Virginia S. Arnold, Benjamin A. Weinberg
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Purvi Jonnalagadda, Virginia S. Arnold, Benjamin A. Weinberg
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review
Mengting Chen, Hongsen Liu, Yufei Xiao, et al.
Clinica Chimica Acta (2025), pp. 120176-120176
Closed Access
Mengting Chen, Hongsen Liu, Yufei Xiao, et al.
Clinica Chimica Acta (2025), pp. 120176-120176
Closed Access
N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
Ronit Juthani, Ashish Manne
Frontiers in Oncology (2025) Vol. 15
Open Access
Ronit Juthani, Ashish Manne
Frontiers in Oncology (2025) Vol. 15
Open Access
THZ1: Towards KRAS mutation‐based precision medicine against pancreatic ductal adenocarcinoma
Yansong Qin, Mancang Gu, Yan Shi, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 3
Open Access
Yansong Qin, Mancang Gu, Yan Shi, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 3
Open Access
